Strength for Caring

Caregivers of patients with cancer experience significant stress. The anxiety and depression of caring for patients with cancer actually causes physical changes in the caregiver, including so-called oxidative stress, and leaky kidneys.


Adult family members and friends are viewed as an unpaid extension of the health care system, providing an estimated 80 percent of all long-term care services in the U.S. But these contributions often come at a significant price for these individuals. According to a large and growing body of scientific literature, the economic, emotional and physical impact of family caregiving can be substantial.


If you care for someone with cancer, get the help you need.


Strength for Caring (www.strengthforcaring.com) is the first national program for cancer caregivers to address both the physical and psychosocial health needs of the patient and caregiver. Free workshops which are facilitated by trained nurses and social workers are held at health care facilities and advocacy organizations across the United States. The website includes caregiving tips and resources, information about cancer side effects, caregiving training videos and an updated listing of Strength for Caring programs in local communities.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap